ClassID:

94467

C07D237/20 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Nitrogen atoms

Recent Application in this class:
#1
20260138956
2026-05-21

NOVEL COMPOUNDS AND USES THEREOF

#2
20260055078
2026-02-26

COMPOUND FUNCTIONING AS SMARCA2/4 INHIBITOR AND USE THEREOF

#3
20250353832
2025-11-20

PROCESS FOR THE PREPARATION OF AMINOPYRIDAZINE DERIVATIVES

#4
20250304571
2025-10-02

BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF

#5
20250304560
2025-10-02

MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS

#6
20250270188
2025-08-28

NLRP3 INFLAMMASOME INHIBITORS

#7
20250214930
2025-07-03

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

#8
20250179013
2025-06-05

INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF

#9
20250122152
2025-04-17

KAT6 Inhibitors

#10
20240391895
2024-11-28

PYRIDAZINE-CONTAINING COMPOUND AND MEDICINAL USE THEREOF

#11
20240368129
2024-11-07

SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS

#12
20240358019
2024-10-31

HERBICIDAL MALONAMIDES CONTAINING MONOCYCLIC HETEROAROMATIC RINGS

#13
20240308977
2024-09-19

PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3

#14
20240307382
2024-09-19

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#15
20240270701
2024-08-15

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

#16
20240254079
2024-08-01

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

#17
20240254075
2024-08-01

FATTY ACID AMIDE HYDROLASE (FAAH) CLEAVABLE PRODRUGS OF THYROMIMETICS AND COMBINATION WITH PERIPHERALLY RESTRICTED FAAH INHIBITORS

#18
20240166610
2024-05-23

SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES

#19
20240043443
2024-02-08

COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY

#20
20240043395
2024-02-08

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

#21
20240002350
2024-01-04

PROTEIN AND LIPID THERAPEUTIC TARGETS

#22
20230365534
2023-11-16

MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS

#23
20230303495
2023-09-28

PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF

#24
20230257351
2023-08-17

SUBSTITUTED N-PHENYLACETAMIDES HAVING P2X4 RECEPTOR ANTAGONISTIC ACTIVITY

#25
20230201200
2023-06-29

Methods for Treating Huntington’s Disease

#26
20230145050
2023-05-11

Sulphonyl urea derivatives as NLRP3 inflammasome modulators

#27
20230107277
2023-04-06

SUBSTITUTED PYRIDAZINE COMPOUND

#28
20230103415
2023-04-06

SMARCA INHIBITORS AND USES THEREOF

#29
20230080054
2023-03-16

INHIBITORS OF ANOCTAMIN 6 PROTEIN AND USES THEREOF

#30
20230072658
2023-03-09

SMARCA DEGRADERS AND USES THEREOF

#31
20230026907
2023-01-26

PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF

#32
20230021476
2023-01-26

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

#33
20220387428
2022-12-08

1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

#34
20220315534
2022-10-06

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

#35
20220251067
2022-08-11

NLRP3 inflammasome inhibitors

#36
20220185785
2022-06-16

INHIBITORS OF CD40-CD154 BINDING

#37
20210337797
2021-11-04

PREPARATION OF PYRIDAZINYL AMINE COMPOUND AND APPLICATION THEREOF

#38
20210317079
2021-10-14

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

#39
20210276959
2021-09-09

Process for preparing 4-amino-pyridazines

#40
20210275526
2021-09-09

Methods for treating Huntington's disease

#41
20210221781
2021-07-22

Fatty acid analogues and methods of use

#42
20210220408
2021-07-22

ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE

#43
20210171537
2021-06-10

Benzenesulfonamide compouds and their use as therapeutic agents

#44
20210171511
2021-06-10

Benzamide derivatives as PPAR-gamma modulators

#45
20210161144
2021-06-03

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#46
20210070708
2021-03-11

Pharmaceutically Active Compounds

#47
20210032265
2021-02-04

COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY

#48
20210002261
2021-01-07

Sulphonyl urea derivatives as NLRP3 inflammasome modulators

#49
20200361940
2020-11-19

Heterocycle-bound condensed heterocyclic compound or salt thereof, agricultural and horticultural insecticide comprising the compound, and method for using the insecticide

#50
20200361899
2020-11-19

NLRP3 inflammasome inhibitors

#51
20200361898
2020-11-19

NLRP3 inflammasome inhibitors

#52
20200354354
2020-11-12

Benzenesulfonamide compounds and their use as therapeutic agents

#53
20200345732
2020-11-05

1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions

#54
20200345727
2020-11-05

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#55
20200277252
2020-09-03

Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors

#56
20200140453
2020-05-07

COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY

#57
20200140396
2020-05-07

Process for preparing 4-amino-pyridazines

#58
20200115374
2020-04-16

Modulators of indoleamine 2,3-dioxygenase

#59
20200113904
2020-04-16

Methods for treating Huntington's disease

#60
20200017488
2020-01-16

Heterocyclic inhibitors of the sodium channel

#61
20200010421
2020-01-09

Pharmaceutically active compounds

#62
20190358226
2019-11-28

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#63
20190194184
2019-06-27

Benzenesulfonamide compounds and their use as therapeutic agents

#64
20190175606
2019-06-13

Biaryl amide compounds as kinase inhibitors

#65
20190166847
2019-06-06

Molecules having pesticidal utility, and intermediates, compositions, and processes related thereto

#66
20190150452
2019-05-23

MOLECULES HAVEING PESTICIDAL UTILIY AND INTERMEDIATES, COMPOSITIONS AND PROCESSES RELATED THERETO

#67
20190077790
2019-03-14

4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors

#68
20190040040
2019-02-07

Pyridazine derivatives as EAAT2 activators

#69
20190010126
2019-01-10

Sulfonamide compounds and uses as TNAP inhibitors

#70
20190000844
2019-01-03

Methods for treating Huntington's disease

#71
20180312503
2018-11-01

Nitrogen-containing aromatic heterocyclic compound

#72
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

#73
20180141917
2018-05-24

Process for preparing 4-amino-pyridazines

#74
20180127406
2018-05-10

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use

#75
20180098541
2018-04-12

Molecules having pesticidal utility and intermediates, compositions and processes related thereto

#76
20180086720
2018-03-29

Therapeutic compounds and uses thereof

#77
20180029985
2018-02-01

Pharmaceutically active compounds

#78
20170334902
2017-11-23

Benzenesulfonamide compounds and their use as therapeutic agents

#79
20170332635
2017-11-23

Amide compound or salt thereof, agricultural and horticultural insecticide and microbicide comprising the compound, and method for using the insecticide and microbicide

#80
20170319516
2017-11-09

Mitochondrial uncouplers for treatment of metabolic diseases and cancer

#81
20170290828
2017-10-12

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#82
20170275301
2017-09-28

Benzenesulfonyl-asymmetric ureas and medical uses thereof

#83
20170260207
2017-09-14

Biaryl amide compounds as kinase inhibitors

#84
20170239226
2017-08-24

N-substituted-5-substituted phthalamic acids as sortilin inhibitors

#85
20170165241
2017-06-15

Compositions and methods of modulating 15-PGDH activity

#86
20170145003
2017-05-25

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#87
20170137414
2017-05-18

Compounds and their methods of use

#88
20170114070
2017-04-27

INHIBITORS OF THE WNT SIGNALLING PATHWAYS

#89
20170050926
2017-02-23

Benzamide compounds and related methods of use

#90
20170037015
2017-02-09

NOVEL PHENOL DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF

#91
20170002008
2017-01-05

Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels

#92
20160366884
2016-12-22

Amide compound or salt thereof, agricultural and horticultural insecticide and microbicide comprising the compound, and method for using the insecticide and microbicide

#93
20160355479
2016-12-08

Sulfonamide compounds and uses as TNAP inhibitors

#94
20160326139
2016-11-10

Pyridazine compounds, compositions and methods

#95
20160326104
2016-11-10

Cyclohexyl sulfone RORγ modulators

#96
20160287584
2016-10-06

Substituted pyridazines for the treatment of pain

#97
20160200674
2016-07-14

IDO inhibitors

#98
20160068487
2016-03-10

Compounds as diacylglycerol acyltransferase inhibitors

#99
20160038504
2016-02-11

Biaryl amide compounds as kinase inhibitors

#100
20150376212
2015-12-31

Flap modulators

#101
20150376177
2015-12-31

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use

#102
20150368270
2015-12-24

FLAP modulators

#103
20150368231
2015-12-24

N-substituted-5-substituted phthalamic acids as sortilin inhibitors

#104
20150353538
2015-12-10

COMPOUNDS AND THERAPEUTIC USES THEREOF

#105
20150329495
2015-11-19

Pyridazinones as DAAO enzyme inhibitors

#106
20150322018
2015-11-12

Substituted pyridazines as skeletal muscle modulators

#107
20150307445
2015-10-29

Compounds as diacylglycerol acyltransferase inhibitors

#108
20150299138
2015-10-22

Compounds as diacylglycerol acyltransferase inhibitors

#109
20150259357
2015-09-17

FLAP modulators

#110
20150259327
2015-09-17

Chemical Compounds

#111
20150252008
2015-09-10

Flap modulators

#112
20150203480
2015-07-23

Guanidine compound

#113
20150191494
2015-07-09

TETRAHYDROISOQUINOLINES AND INTERMEDIATES THEREFOR

#114
20150175555
2015-06-25

Pyridazine compounds, compositions and methods

#115
20150166525
2015-06-18

Benzene or thiophene derivative and use thereof as VAP-1 inhibitor

#116
20150072998
2015-03-12

Compositions and methods of modulating 15-PGDH activity

#117
20150065517
2015-03-05

NEW COMPOUNDS

#118
20150025235
2015-01-22

Benzamide compounds and related methods of use

#119
20150011558
2015-01-08

Pyridazine derivatives and use thereof as medicaments for treating microRNA viral infection

#120
20150011551
2015-01-08

Sulfonamide compounds and uses as TNAP inhibitors

#121
20140378302
2014-12-25

COMPOSITION FOR CONTROLLING PLANT DISEASES AND USE THEREOF

#122
20140371073
2014-12-18

Plant growth regulating compounds

#123
20140364436
2014-12-11

Protein kinase inhibitors

#124
20140357614
2014-12-04

Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine Hreceptor

#125
20140336381
2014-11-13

Fast-dissociating dopamine 2 receptor antagonists

#126
20140315878
2014-10-23

Chemical compounds

#127
20140275100
2014-09-18

Substituted pyridazines for the treatment of pain

#128
20140275003
2014-09-18

Biaryl amide compounds as kinase inhibitors

#129
20140234939
2014-08-21

Benzamide compounds and related methods of use

#130
20140221311
2014-08-07

Flap modulators

#131
20140221310
2014-08-07

Flap modulators

#132
20140213570
2014-07-31

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#133
20140135496
2014-05-15

Isoxazoline-substituted benzamide compound and pesticide

#134
20140100210
2014-04-10

Guanidine compound

#135
20140051672
2014-02-20

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#136
20140031354
2014-01-30

Protein kinase inhibitors

#137
20130267519
2013-10-10

1,2-pyridazines, 1,6-pyridazines and pyrimidines

#138
20130261299
2013-10-03

Pyridazinyl derivatives as SMO inhibitors

#139
20130231342
2013-09-05

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use

#140
20130225596
2013-08-29

Heterocyclic derivative and pharmaceutical composition comprising the same

#141
20130225584
2013-08-29

2-(benzyloxy) benzamides as LRRK2 kinase inhibitors

#142
20130190319
2013-07-25

Pyridazine derivatives and use thereof as medicaments for treating microRNA viral infection

#143
20130143862
2013-06-06

Amino-pyridazine skeletal muscle modulators

#144
20130143860
2013-06-06

Guanidine compound

#145
20130137691
2013-05-30

DERIVATIVES OF OXADIAZOLE AND PYRIDAZINE, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS

#146
20130072496
2013-03-21

Formulations containing pyridazine compounds

#147
20130060027
2013-03-07

TETRAHYDROISOQUINOLINES AND INTERMEDIATES THEREFOR

#148
20130029999
2013-01-31

Myosin light chain kinase inhibitor compounds, compositions and related methods of use

#149
20130018074
2013-01-17

NEW COMPOUNDS

#150
20130018054
2013-01-17

(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity

#151
20130018046
2013-01-17

Acetylenic heteroaryl compounds

#152
20120329786
2012-12-27

COMPOUNDS AND THERAPEUTIC USES THEREOF

#153
20120289507
2012-11-15

Pyridazinyl derivatives as smo inhibitors

#154
20120245125
2012-09-27

Pyridazine compounds, compositions and methods

#155
20120238578
2012-09-20

Compositions useful as inhibitors of voltage-gated sodium channels

#156
20120238574
2012-09-20

(1, 1, 1,3,3,3-hexafluoro-2 hydroxypropan-2-yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis

#157
20120232078
2012-09-13

Medicaments

#158
20120184553
2012-07-19

Compounds

#159
20120165339
2012-06-28

CYCLOPROPANE DERIVATIVES

#160
20120010182
2012-01-12

Chemical compounds

#161
20120004231
2012-01-05

Substituted pyridazine derivatives

#162
20110288076
2011-11-24

Acetanilide sphingosine-1-phosphate receptor antagonists

#163
20110281885
2011-11-17

THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN

#164
20110275641
2011-11-10

Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#165
20110275640
2011-11-10

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#166
20110230428
2011-09-22

CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

#167
20110160220
2011-06-30

Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine

#168
20110160187
2011-06-30

3-aryl-5,6-disubstituted pyridazines

#169
20110144334
2011-06-16

Isoxazoline-substituted benzamide compound and pesticide

#170
20110112107
2011-05-12

Substituted 6-(1-piperazinyl)-pyridazines as 5-HTreceptor antagonists

#171
20110108767
2011-05-12

COMPOSITION, AND LIGHT-EMISSION ELEMENT PRODUCED BY USING THE COMPOSITION

#172
20110105543
2011-05-05

NOVEL TRIARYL DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#173
20110104162
2011-05-05

Compounds which can be used for the treatment of cancers

#174
20110092474
2011-04-21

Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor

#175
20110077400
2011-03-31

Tetrahydroisoquinolines and intermediates therefor

#176
20110059978
2011-03-10

Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors

#177
20110059957
2011-03-10

Benzene or thiophene derivative and use thereof as VAP-1 inhibitor

#178
20110039860
2011-02-17

SOLUBLE EPOXIDE HYDROLASE INHIBITORS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

#179
20110021530
2011-01-27

PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS

#180
20110003815
2011-01-06

DIPHENYL SUBSTITUTED CYCLOALKANES

#181
20100317665
2010-12-16

Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

#182
20100311763
2010-12-09

Pyridazine derivatives and their use as therapeutic agents

#183
20100311752
2010-12-09

Substituted pyridazine derivatives

#184
20100305124
2010-12-02

Acylated Aminopyridine and Aminopyridazine Insecticides

#185
20100286131
2010-11-11

VIRAL POLYMERASE INHIBITORS

#186
20100267945
2010-10-21

Amine derivative having NPY Y5 receptor antagonistic activity

#187
20100267739
2010-10-21

TREATMENT OF AFFECTIVE DISORDERS BY THE COMBINED ACTION OF A NICOTINIC RECEPTOR AGONIST AND A MONOAMINERGIC SUBSTANCE

#188
20100240668
2010-09-23

Myosin light chain kinase inhibitor compounds, compositions and related methods of use

#189
20100240654
2010-09-23

HYDRAZIDE DERIVATIVES

#190
20100234389
2010-09-16

AMIDE COMPOUND

#191
20100190761
2010-07-29

DIPHENYL SUBSTITUTED ALKANES

#192
20100144805
2010-06-10

Regulation of protein synthesis

#193
20100144741
2010-06-10

ETHANOLAMINE DERIVATIVES USEFUL AS BACE INHIBITORS

#194
20100144733
2010-06-10

Compounds, compositions and methods comprising heteroaromatic derivatives

#195
20100113466
2010-05-06

OXAZOLE-PYRIDAZINE-OXAZOLE ALPHA-HELIX MIMETIC

#196
20100087479
2010-04-08

Compositions useful as inhibitors of voltage-gated sodium channels

#197
20100069394
2010-03-18

Fast-dissociating dopamine 2 receptor antagonists

#198
20100063027
2010-03-11

Amine derivative having NPY Y5 receptor antagonistic activity

#199
20100041663
2010-02-18

Organic Compounds as Smo Inhibitors

#200
20100016304
2010-01-21

Glucokinase activator

#201
20090325973
2009-12-31

FORMULATIONS CONTAINING PYRIDAZINE COMPOUNDS

#202
20090325956
2009-12-31

Aromatic amine derivative and use thereof

#203
20090312309
2009-12-17

Medicaments

#204
20090286809
2009-11-19

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#205
20090286794
2009-11-19

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#206
20090270398
2009-10-29

Compounds, Compositions and Methods Comprising Pyridazine Derivatives

#207
20090264435
2009-10-22

Novel Aryl- and Heteroarylpiperazines

#208
20090264425
2009-10-22

CHEMICAL COMPOUNDS

#209
20090264424
2009-10-22

VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS

#210
20090256468
2009-10-15

Novel organic electroluminescent compounds and organic electroluminescent device using the same

#211
20090247534
2009-10-01

Compounds

#212
20090227592
2009-09-10

Compounds effecting glucokinase

#213
20090197890
2009-08-06

Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

#214
20090192136
2009-07-30

Benzoyl-piperazine derivatives

#215
20090176781
2009-07-09

Acetylenic heteroaryl compounds

#216
20090163508
2009-06-25

AMIDE COMPOUND

#217
20090105475
2009-04-23

Process for producing 2,3-dihydropyridazine compound

#218
20090062294
2009-03-05

HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE

#219
20090054444
2009-02-26

Substituted phenylacetamides and their use as glucokinase activators

#220
20090048263
2009-02-19

Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder

#221
20090030008
2009-01-29

Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

#222
20090018056
2009-01-15

Heteroarylcarbamoylbenzene derivatives

#223
20090012088
2009-01-08

Compounds for the Treatment of Neurodegeneration and Stroke

#224
20080318948
2008-12-25

Organic compounds

#225
20080318899
2008-12-25

Pyridazine compounds, compositions and methods

#226
20080280916
2008-11-13

Pyridazine derivatives and their use as therapeutic agents

#227
20080269232
2008-10-30

Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors

#228
20080207636
2008-08-28

Compounds effecting glucokinase

#229
20080182851
2008-07-31

ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS

#230
20080182846
2008-07-31

Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#231
20080153835
2008-06-26

Therapeutic agents useful for treating pain

#232
20080132507
2008-06-05

Hydrazide Derivatives

#233
20080092307
2008-04-24

Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds

#234
20080021035
2008-01-24

Myosin light chain kinase inhibitor compounds, compostions and related methods of use

#235
20070265241
2007-11-15

TREATMENT OF AFFECTIVE DISORDERS BY THE COMBINED ACTION OF A NICOTINIC RECEPTOR AGONIST AND A MONOAMINERGIC SUBSTANCE

#236
20070249050
2007-10-25

Substituted aromatic compounds for inflammation and immune-related uses

#237
20070238700
2007-10-11

N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES

#238
20070213330
2007-09-13

Inhibitors of histone deacetylase

#239
20070203207
2007-08-30

Heteroaromatic glucokinase activators

#240
20070100141
2007-05-03

Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor

#241
20070049571
2007-03-01

Dipiperazinyl ketones and related analogues

#242
20070032500
2007-02-08

Therapeutic agents useful for treating pain

#243
20070032496
2007-02-08

Compounds for the Treatment of Neurodegeneration and Stroke

#244
20060252767
2006-11-09

Piperazine derivatives and their use as therapeutic agents

#245
20060235021
2006-10-19

Phenylpyridazine derivatives as ligands for gaba receptors

#246
20060205713
2006-09-14

Pyridazine derivatives and their use as therapeutic agents

#247
20060189613
2006-08-24

Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4)

#248
20060173012
2006-08-03

Piperazines

#249
20060167053
2006-07-27

Heteroarylcarbamoylbenzene derivative

#250
20060122062
2006-06-08

Substituted iminoazines

#251
20060116377
2006-06-01

Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses

#252
20060073472
2006-04-06

Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

#253
20060052597
2006-03-09

Aryloxyalkylamine derivatives as h3 receptor ligands

#254
20060030618
2006-02-09

Vanilloid receptor ligands and their use in treatments

#255
20060025415
2006-02-02

Compositions useful as inhibitors of voltage-gated sodium channels

#256
20060014743
2006-01-19

Methods of preventing bacterial infections with florfenicol-type antibiotics

#257
20060009459
2006-01-12

Pyridazine derivatives and their use as therapeutic agents

#258
20050277646
2005-12-15

Vanilloid receptor ligands and their use in treatments

#259
20050272931
2005-12-08

Vanilloid receptor ligands and their use in treatments

#260
20050267163
2005-12-01

Vanilloid receptor ligands and their use in treatments

#261
20050261503
2005-11-24

Heteroaromatic glucokinase activators

#262
20050245518
2005-11-03

Inhibitors of histone deacetylase

#263
20050234046
2005-10-20

Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders

#264
20050227986
2005-10-13

Vanilloid receptor ligands and their use in treatments

#265
20050222412
2005-10-06

Peptide deformylase inhibitors

#266
20050176706
2005-08-11

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof

#267
20050153984
2005-07-14

Vanilloid receptor ligands and their use in treatments

#268
20050137212
2005-06-23

hPPARs activators

#269
20050137190
2005-06-23

Compositions useful as inhibitors of voltage-gated sodium channels

#270
20050107381
2005-05-19

6-membered heteroaryl compounds for the treatment of neurodegenerative disorders

#271
20050080106
2005-04-14

Compounds effecting glucokinase

#272
20050075507
2005-04-07

1,2,4-Triazole derivative, method for preparing the same, and pharmaceutical composition containing the same

#273
20050070539
2005-03-31

Benzoyl-piperazine derivatives

#274
20050065143
2005-03-24

Pyridazine derivatives and their use as therapeutic agents

#275
20050054732
2005-03-10

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

#276
20050028300
2005-02-10

Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds

#277
16821294
2020-10-27

Benzenesulfonamide compounds and their use as therapeutic agents